Identifying, Characterizing, and Understanding Nefiracetam in Its Solid State Forms: A Potential Antidementia Drug

Area of Science:

• Pharmaceutical Sciences
• Solid-State Chemistry

Background:

• Nefiracetam is a nootropic drug with potential therapeutic applications.
• Understanding the solid-state properties of active pharmaceutical ingredients is crucial for formulation development.

Purpose of the Study:

• To identify and characterize novel solid-state forms of Nefiracetam.
• To evaluate the structural, thermodynamic, and dissolution properties of these new forms.
• To assess their suitability for alternative pharmaceutical formulations.

Main Methods:

• X-ray powder diffraction (XRPD) for structural analysis.
• Differential scanning calorimetry (DSC) and thermogravimetric analysis (TGA) for thermal properties.
• Solubility and dissolution rate studies in relevant media.

Main Results:

• Three new solid-state forms of Nefiracetam were identified: one monohydrate and two anhydrous polymorphs.
• Detailed structural and thermodynamic data were obtained for each form.
• Significant differences in dissolution rates and solubilities were observed among the identified forms.

Conclusions:

• The newly identified solid-state forms of Nefiracetam offer diverse physicochemical properties.
• These findings provide a basis for selecting optimal forms for developing novel Nefiracetam formulations.
• Further investigation into the bioavailability of these forms is warranted.